Countdown to BIOHK2026: World-Class Biotech Convention Prepares to Host Global Pavilions, Multi-Track Forums, and Signature Executive Networking
HONG KONG, Aug. 27, 2026 /PRNewswire/ -- As a premier global landmark in biotech, BIOHK2026 convenes international biotech hubs, cross-disciplinary industry forums, and high-impact networking events to accelerate cross-border partnerships in Hong Kong. The official countdown is underway. With just two weeks until BIOHK2026 convenes at the Hong Kong Convention and Exhibition Centre (HKCEC)...
Exascend Deploys Advanced Medical-Grade Storage Solutions to Power Next-Generation Healthcare Systems
TAIPEI, Aug. 27, 2026 /PRNewswire/ -- Exascend announced the successful deployment of its Medical-Grade Storage Solutions in collaboration with a leading healthcare technology provider, supporting the demanding requirements of next-generation medical systems. The enterprise-grade solution delivers reliable performance, data security, and thermal management for medical devices and healthcare systems where storage reliability is critical to system operation. Modern medical...
Cansurvive to hold 16th International Conference on Holistic Healing from Cancer spotlighting the link between infection and cancer
KUALA LUMPUR, Malaysia, Aug. 27, 2026 /PRNewswire/ -- Cansurvive Centre Malaysia Berhad, a non-profit cancer charity organisation, announces its 16th Malaysian International Conference on Holistic Healing from Cancer, themed "Cancer & Infection: Breaking the Cycle". The full-day conference will be held on Saturday, 19 September 2026, from 8.30am to 5.00pm, at the Omnia Auditorium, Brickfields Asia College (BAC),...
Nature Biotechnology | Aureka Wins the Global Blinded AI Antibody Benchmark: AI Design Surpasses the Best Experimental Result
SHANGHAI and LAGUNA HILLS, Calif., Aug. 27, 2026 /PRNewswire/ -- The complete results of AIntibody, the first international AI antibody design competition, have now been formally published in Nature Biotechnology. Figure 1 | Screenshot of the Nature Biotechnology paper Widely regarded as the field's most rigorous test — every entry validated by independent wet-lab experiments under identical...
Biosidus expands biologics manufacturing capacity and strengthens global supply capabilities for agalsidase beta
BUENOS AIRES, Argentina, Aug. 27, 2026 /PRNewswire/ -- Biosidus, an Argentine biotechnology company with more than four decades of experience in the development and manufacturing of biosimilar medicines, announced that its new bioreactor plant is now operational, increasing the company's biologics production capacity and reinforcing its ability to support potential international demand. Biosidus works to improve people's...
Viva Biotech Announces Its 2026 Interim Results: AI Sparks New Paradigm in Drug R&D, CDMO Commercial Manufacturing Accelerates Revenue Growth
Results Highlights for Interim Results ended 30 June 2026Revenue reached RMB1,006.5 million, increasing by 21.0% YoYGross profit amounted to RMB341.7 million, increasing by 0.7% YoYGross profit margin was 34.0% HONG KONG, Aug. 26, 2026 /PRNewswire/ -- On August 26, 2026, Viva Biotech Holdings Group ("the Group" or "the Company", stock code:...
Piramal Pharma Strengthens Future Ready Operations with 22.6% Emissions Reduction, 41% Renewable Energy and Zero USFDA OAI Observations
Lowest-ever Scope 1 and Scope 2 emissions mark a milestone year in the Company's SBTi-approved decarbonisation journey MUMBAI, India, Aug. 26, 2026 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), a leading global pharmaceuticals company, today released its Sustainability Report 2025–26, showcasing significant progress across its environmental, social and...
ReviR Therapeutics Receives FDA Rare Pediatric Disease Designation for RTX-117 in Charcot-Marie-Tooth Disease
Designation supports the global development of RTX-117 and may provide potential future access to a transferable Priority Review Voucher, subject to approval and applicable requirements BRISBANE, Calif., Aug. 26, 2026 /PRNewswire/ -- ReviR Therapeutics, a clinical-stage biotechnology company advancing small-molecule therapies through the integration of artificial intelligence and RNA biology, today announced that the U.S. Food and Drug...
DarwinHealth Introduces Quantum Cancer Biology: A Cell-State Systems Biology Framework for Precision Oncology
New paradigm integrates single-cell transcriptomics, regulatory network inference, and AI to decode—and therapeutically target—the multiple, co-existing cancer cell states that drive resistance in pancreatic cancer, glioblastoma, and other lethal malignancies NEW YORK, Aug. 26, 2026 /PRNewswire/ -- DarwinHealth, a New York-based, AI-centric biotechnology company. today announced the introduction of Quantum Cancer Biology:...
Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays
SEATTLE and RICHMOND, BC, Aug. 26, 2026 /PRNewswire/ -- Monod Bio, a Seattle-based AI-enabled protein design company, and SignalChem Biotech Inc., a wholly-owned subsidiary of Sino Biological, Inc. (SZSE: 301047), today announced a non-exclusive licensing agreement covering Monod Bio's proprietary LuxSit de novo luciferase technology and NovoBodies. Under the...
